Suppr超能文献

羟基红花黄色素A通过抑制线粒体通透性转换孔开放保护心脏免受缺血-再灌注损伤的证据。

Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.

作者信息

Liu Yi-Na, Zhou Zhong-Min, Chen Peng

机构信息

Department of Cardiology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

出版信息

Clin Exp Pharmacol Physiol. 2008 Feb;35(2):211-6. doi: 10.1111/j.1440-1681.2007.04814.x. Epub 2007 Oct 17.

Abstract
  1. The present study was conducted to investigate whether hydroxysafflor yellow A (HSYA) has a protective effect against heart injury after ischaemia-reperfusion and to determine the possible mechanism involved. 2. Hearts isolated from male Sprague-Dawley rats were perfused on a Langendorff apparatus and subjected to 30 min global ischaemia, followed by 120 min reperfusion. Infarct size and the level of lactate dehydrogenase (LDH) in the coronary effluent were determined. In mitochondria from isolated perfused hearts, Ca(2+)-induced swelling was observed. In isolated ventricular myocytes, depolarization of the mitochondrial membrane was determined by tetramethyl-rhodamine ethyl ester (TMRE) fluorescence. Furthermore, levels of phosphorylated endothelial nitric oxide synthase (eNOS) protein were measured by western blot. 3. Pretreatment with HSYA for 5 min before ischaemia reduced infarct size and the release of LDH. Administration of 20 micromol/L atractyloside, an opener of the mitochondrial permeability transition pore, and 10 micromol/L N(G)-nitro-L-arginine methyl ester (L-NAME), an inhibitor of NOS, attenuated the protective effects of HSYA. In mitochondria isolated from hearts pretreated with 0.1 mmol/L HSYA for 5 min, a significant inhibition of Ca(2+)-induced swelling was observed and this inhibition was attenuated by l-NAME. In isolated ventricular myocytes, pretreatment with HSYA prevented ischaemia-induced cell death and depolarization of the mitochondrial membrane, whereas atractyloside or l-NAME attenuated the effects of HSYA. Levels of phosphorylated eNOS protein were significantly enhanced in the HSYA-treated group. 4. The findings of the present study indicate that HSYA protects the myocardium against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. The effect of HSYA on mitochondrial permeability transition pore opening may be mediated through enhanced nitric oxide production by eNOS activation.
摘要
  1. 本研究旨在探讨羟基红花黄色素A(HSYA)对缺血再灌注后心脏损伤是否具有保护作用,并确定其可能的作用机制。2. 从雄性Sprague-Dawley大鼠分离出的心脏在Langendorff装置上进行灌注,经历30分钟全心缺血,随后再灌注120分钟。测定梗死面积以及冠状动脉流出液中乳酸脱氢酶(LDH)的水平。在分离的灌注心脏的线粒体中,观察Ca(2+)诱导的肿胀。在分离的心室肌细胞中,通过四甲基罗丹明乙酯(TMRE)荧光测定线粒体膜的去极化。此外,通过蛋白质印迹法测量磷酸化内皮型一氧化氮合酶(eNOS)蛋白的水平。3. 缺血前用HSYA预处理5分钟可减小梗死面积并减少LDH的释放。给予20微摩尔/升的苍术苷(一种线粒体通透性转换孔开放剂)和10微摩尔/升的N(G)-硝基-L-精氨酸甲酯(L-NAME,一种一氧化氮合酶抑制剂)可减弱HSYA的保护作用。在用0.1毫摩尔/升HSYA预处理5分钟的心脏分离出的线粒体中,观察到对Ca(2+)诱导的肿胀有显著抑制作用,且这种抑制作用被L-NAME减弱。在分离的心室肌细胞中,HSYA预处理可预防缺血诱导的细胞死亡和线粒体膜去极化,而苍术苷或L-NAME可减弱HSYA的作用。在HSYA处理组中,磷酸化eNOS蛋白的水平显著升高。4. 本研究结果表明,HSYA通过抑制线粒体通透性转换孔开放来保护心肌免受缺血再灌注损伤。HSYA对线粒体通透性转换孔开放的作用可能是通过eNOS激活增强一氧化氮生成来介导的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验